Phenomix Corp.
This article was originally published in Start Up
Executive Summary
High-tech discovery methods so broadly embraced over the past decade haven't delivered expected gains in productivity. Phenomix Corp. thinks it will fare better by harnessing mouse models of disease, randomly mutagenizing genes, checking the resulting phenotypes for beneficial changes then tracking back to the gene.